The cytochrome P450 inhibitor, ketoconazole, inhibits oxidized linoleic acid metabolite-mediated peripheral inflammatory pain
<p>Abstract</p> <p>Background</p> <p>Oxidized linoleic acid metabolites (OLAMs) are a class of endogenous agonists to the transient receptor potential V1 (TRPV1) receptor. Although TRPV1 mediates inflammatory heat hyperalgesia, it is not known if the OLAMs contribute to...
Saved in:
Main Authors: | Ruparel Shivani (Author), Green Dustin (Author), Chen Paul (Author), Hargreaves Kenneth M (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2012-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Two-way pharmacokinetic interaction studies between saxagliptin and cytochrome P450 substrates or inhibitors: simvastatin, diltiazem extended-release, and ketoconazole
by: Patel C, et al.
Published: (2011) -
Editorial: Cytochromes P450, their modulators and metabolites in cardiovascular function and disease
by: Adeniyi M. Adebesin, et al.
Published: (2024) -
Succinic acid inhibits the activity of cytochrome P450 (CYP450) enzymes
by: Hao Wang, et al.
Published: (2020) -
Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma
by: Can G. Leineweber, et al.
Published: (2023) -
Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma
by: Can G. Leineweber, et al.
Published: (2024)